50 Senators Voted to Keep Medicare's AI Denials

Introduction

Fifty Senate Republicans voted on July 16 to keep an AI system running inside Traditional Medicare, and not one of them crossed over. The program they protected is called WISeR. It routes a doctor's order for something like an epidural or a knee scope through one of six private contractors before Medicare will pay, and three of those contractors are financed by the same insurers whose Medicare Advantage denial practices Congress has spent two years investigating: Blue Cross Blue Shield, UnitedHealth's Optum, and Kaiser Permanente. If you're on Traditional Medicare in Texas, Oklahoma, New Jersey, Ohio, Washington, or Arizona, or you're the adult kid arranging a parent's care in one of those states, that vote was the single chance to switch the thing off.

The vote only happened because CMS got caught. In writing, to a federal watchdog, the agency argued that WISeR was a "guidance document" exempt from the one law that lets Congress overturn it. The watchdog said that was wrong and forced the floor vote anyway. Then every Republican present used it to protect the program CMS had tried to keep off the floor in the first place.

The Watchdog Ruling That Forced a Floor Vote

The Congressional Review Act lets Congress void a federal rule with a simple majority and no filibuster, but only inside a 60-day window after the agency submits that rule for review. CMS never submitted WISeR. So in December 2025, Senators Ron Wyden, Patty Murray, Richard Blumenthal, and Kirsten Gillibrand asked the Government Accountability Office a narrow question: is this thing a "rule" that CMS was legally required to hand over?

On May 12, 2026, the GAO said yes, in Decision B-337994. That determination reset the CRA's clock and let Wyden force S.J. Res. 198 onto the floor on a fast track leadership couldn't bottle up, the exact vote CMS's whole rollout was designed to avoid.

WISeR launched in January across six states, aimed at Traditional Medicare, the program that, unlike Medicare Advantage, had never made seniors ask permission before care in its 60-year history. CMS picked six private companies to run the pre-payment reviews and pays them out of the money they help the government not spend. The ownership records explain why. Humata Health, the Oklahoma vendor, closed a $25 million round led by Blue Venture Fund, which speaks for most Blue Cross Blue Shield plans, with UnitedHealth's Optum Ventures also chipping in. Innovaccer, the Ohio vendor, took a $275 million Series F led by Kaiser Permanente. Cohere Health, in Texas, runs on venture money and a direct partnership with Humana.

"A Guidance Document," in CMS's Own Words

The decision is worth reading because it quotes CMS's defense back at it. Asked to justify skipping review, HHS told the GAO that "the WISeR Model Notice is a guidance document and the CRA does not apply to guidance documents." The GAO had heard that one before. It cited its own precedent that agency guidance, even the kind an agency calls non-binding, still counts as a rule, then worked through the three exemptions a rule can claim and rejected each: WISeR isn't of "particular applicability," isn't a matter of CMS's internal management, and isn't a harmless procedural rule, since it decides whether a senior's claim gets paid.

There's a second admission in the response. HHS confirmed it had never filed a CRA report with Congress or the Comptroller General at all, arguing that quietly notifying "individual member offices and certain committees" covered its obligation. The GAO said it didn't.

Fifty Nays, and the House Vote That Complicates Them

When the vote to advance it came on July 16, it broke cleanly along party lines: 46 yeas, 50 nays. Every yea came from a Democrat or one of the two independents who caucus with them; every nay came from a Republican. Because a CRA resolution needs only a simple majority, those 50 nays were enough to sink it with nothing to spare. Senate Finance Chairman Mike Crapo gave his reason: ending the pilot "prematurely will deprive CMS of a useful tool."

Most of the vote-day coverage skipped what happened five weeks earlier. A Republican-controlled House Appropriations Committee had voted to defund WISeR entirely for fiscal 2027, by a bipartisan voice vote, with no Republican blocking it. In one chamber, GOP members voted to zero the program out; a month later in the other, GOP members closed ranks to keep it alive, less a verdict on WISeR's merits than a move to shield the administration from losing a rule to Congress.

Michael Edgerly Waited Seven Weeks

Michael Edgerly is 78, a retired mailman in Cle Elum, Washington, with scoliosis and degenerative joint disease. He applied for an epidural steroid injection in February. WISeR denied it on March 4. It cleared on March 30, about seven weeks after he started, and he canceled an anniversary cruise because nothing touched the pain in between. His case sits in Sen. Maria Cantwell's snapshot report, built from a survey of 16 Washington hospitals. That same report found the University of Washington's system watched prior-auth turnaround stretch from the 1-to-3 days CMS promises to an actual 15 to 20, with almost 100 patients waiting on epidural injections the week it published.

Washington isn't the outlier. KFF Health News documented a WISeR denial in Oklahoma that cited "numbness" as disqualifying, even though the radiologist had noted four separate times in the chart that the patient had none. KFF also found Bill Curry, a cattle farmer near Tulsa, dragged into an extra 10-hour round trip for the same quarterly epidural he'd gotten for years, who now says he'd sooner drive to Kansas than deal with WISeR again. Providers across the pilot states report weeks-long payment backlogs on clean claims. And CMS still hasn't released denial-rate data for any of the six states, six months in, past a 31-Democrat letter demanding it by July 15 and an EFF lawsuit filed to force it out.

Who Benefits

The six vendors get paid a share of what they help Medicare avoid spending, so every denial and every delay that sticks is revenue for them. The bigger prize goes to the insurers behind them. For 60 years, Traditional Medicare's one structural edge over Medicare Advantage was that it didn't make seniors get permission before treatment. WISeR erases that edge and hands the keys to companies funded by Blue Cross Blue Shield, UnitedHealth, Kaiser, and Humana, the same industry whose Medicare Advantage prior-auth denials the Senate's own investigators spent 2024 documenting. CMS's own Federal Register justification says it picked these vendors for their "demonstrated success" running Medicare Advantage prior authorization, the very practice this whole fight is about.

The government tier gets something less tangible and just as real. Keeping WISeR alive lets the administration hold onto the "waste, fraud, and abuse" mantle without the embarrassment of a flagship program struck down by Congress. STAT News reported that CMS handed lawmakers' offices a written defense of the program the Tuesday before the vote. That's an agency lobbying the branch meant to oversee it, days after that branch's own auditor ruled CMS should have submitted the program for review in the first place. Every senator who held the line also spared the Innovation Center the precedent of losing a model to a CRA vote.

When the Agency and the Senate Answer to One Party

This is the part that sticks with me. The CRA worked exactly as designed, right up to the moment it counted. It's the tool Congress built for one precise scenario, an agency pushing out a rule and skipping the review step, and the GAO caught the skip cleanly, on the law. Then the mechanism handed the decision to a Senate where the majority and the agency answer to the same president, and on July 16, that's exactly where the check stopped.

Which is why the CRA resolution was probably never the real fix. Even passing it would only have voided this one WISeR notice, leaving CMS free to relaunch a near-identical model under a new name. The permanent bar is H.R. 6361, the Ban AI Denials in Medicare Act, which would amend the Social Security Act so HHS can't run a prior-auth payment model like this at all. It's sat in committee since December with no floor vote scheduled. The reason any of this reaches past six states is what a family doctor in Oklahoma told KFF: if the pilot "works," meaning if it saves money, that logic gets extended to more procedures and more states. WISeR is the proof of concept for prior authorization across all of Traditional Medicare.

The Bottom Line

On July 16, a federal watchdog caught CMS routing around Congress and handed Congress the rare tool to answer. The Senate used it to give the end-run fifty votes.

Two threads are still live. The House Appropriations Committee's defunding language is riding the FY2027 spending bill, and whether it survives into enacted law will show whether that bipartisan committee vote was real or a cheap one taken because everyone knew the Senate would hold. And CMS still hasn't turned over a single denial rate, half a year into a program running on hundreds of thousands of seniors' claims. If WISeR is working as well as the fifty senators who saved it say, why is the data the one thing nobody in charge will let you see?